Research & Development



  “我本世上逍遙客,君是深閨夢里人!”   一件粉紅色的里衣吸引了老虎大王的眼球,他湊到里衣跟前用力的嗅嗅,覺得肥皂味道很好,準備將這件里衣摘下來的時候,身後有婦人刺耳的尖叫聲傳來。超碰97资源站   雲氏之所以答應,是因為雲氏的重心從來就不在土地上,你拿走多少,只要不拿走雲氏的居住地,雲瑯沒有不答應的。”色久久综合网   “這麼說,我也應該弄一些番僧回來教我修煉,就這麼定了,那些瑜伽天女屁用不頂,三五次之後就沒了興致,阿瑯,你要不要番僧?”   今天要開全家會議,商談雲哲娶親的事情,雖然雲瑯不習慣兒子十七歲就成親,奈何藍田已經十九歲了,在不娶親,藍田的日子就不好過了。色图网   只是蹲了片刻就眼冒金星,兩個嬌美的婦人匆忙將他攙扶起來,讓他重新靠在那張可以移動的錦榻上。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo